When did Zoetis report Q2 2025 earnings?

Zoetis (ZTS) reported Q2 2025 earnings on August 5, 2025 before market open.

What were Zoetis's Q2 2025 revenue and EPS?

Zoetis reported revenue of $2.5B and diluted EPS of $1.76 for Q2 2025.

Did Zoetis beat estimates in Q2 2025?

Revenue beat the consensus estimate of $2.4B by $50.5M. EPS beat the consensus estimate of $1.62 by $0.14.

How did Zoetis's Q2 2025 results compare year-over-year?

Compared to the same quarter a year prior, revenue grew 4.2% from $2.4B a year earlier and diluted EPS grew 12.8% from $1.56.

Where can I find Zoetis's Q2 2025 SEC filings?

You can read the 10-Q periodic report (0001555280-25-000261) directly on SEC EDGAR. The filing index links above go to sec.gov.

Zoetis ZTS Q2 2025 earnings

Reported August 5, 2025 · Before market open

Revenue$2.5BBeat by $50.5M Diluted EPS$1.76Beat by $0.14

Revenue estimate$2.4B

EPS estimate$1.62

Next report

Aug 6, 2026 (In 3 weeks)

Revenue estimate$2.5B

EPS estimate$1.85

Financials

Q2 2025

Income statement

See full

Revenue$2.5B+4.2%

Gross profit$1.8B+7.0%

Net income$718.0M+15.1%

EPS (diluted)$1.61+17.5%

Balance sheet

See full

Cash & equivalents$1.4B-8.8%

Total debt$6.8B+0.7%

Total equity$5.0B+0.2%

Total assets$14.5B+2.2%

Cash flow

See full

Operating cash flow$558.0M+11.2%

CapEx$149.0M+12.9%

Free cash flow$409.0M+10.5%

Valuation & ratios

Valuation

as of 06/30/25

See full

Market cap$70.24B-11.5%

Enterprise value$75.6B-10.6%

P/E27.2×-6.7×

P/S7.5×-1.4×

Profitability

See full

Gross margin71.4%+1.5pp

Net margin27.6%+1.3pp

FCF margin23.7%+0.1pp

Returns & leverage

See full

Return on equity52%+3.1pp

Debt / equity1.4×0.0×

Current ratio1.8×-1.7×

Segments

By product

See full

Parasiticides$673.0M+12.2%

Vaccines$504.0M+13.3%

Dermatology$463.0M+10.8%

Anti-infectives$219.0M-17.0%

Pain and sedation$217.0M-1.8%

By segment

See full

U.S.$1.4B+3.7%

International$1.1B+3.4%

Versus estimates

Revenue

Q1 2026$2.3BMiss by $39.4M Q4 2025$2.4BBeat by $27.0M Q3 2025$2.4BMiss by $10.0M

Q2 2025$2.5BBeat by $50.5M

Q1 2025$2.2BBeat by $30.1M Q4 2024$2.3BBeat by $19.8M

Diluted EPS

Q1 2026$1.53Miss by $0.07 Q4 2025$1.48Beat by $0.08 Q3 2025$1.70Beat by $0.08

Q2 2025$1.76Beat by $0.14

Q1 2025$1.48Beat by $0.07 Q4 2024$1.40Beat by $0.03

Ask the moment Zoetis reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Zoetis report Q2 2025 earnings?: Zoetis (ZTS) reported Q2 2025 earnings on August 5, 2025 before market open.
What were Zoetis's Q2 2025 revenue and EPS?: Zoetis reported revenue of $2.5B and diluted EPS of $1.76 for Q2 2025.
Did Zoetis beat estimates in Q2 2025?: Revenue beat the consensus estimate of $2.4B by $50.5M. EPS beat the consensus estimate of $1.62 by $0.14.
How did Zoetis's Q2 2025 results compare year-over-year?: Compared to the same quarter a year prior, revenue grew 4.2% from $2.4B a year earlier and diluted EPS grew 12.8% from $1.56.
Where can I find Zoetis's Q2 2025 SEC filings?: You can read the 10-Q periodic report (0001555280-25-000261) directly on SEC EDGAR. The filing index links above go to sec.gov.